Available online 10 March 2022, 100817

While radiofrequency ablation (RFA) for the treatment of symptomatic thyroid nodules has been gaining more wide spread adoption in the United States, there is limited societal guidance for its role and safe adoption. As many of the first adopters of thyroid nodule RFA developed their practices, they looked to the Korean Society of Interventional Radiology (KSIR) and European Thyroid Association (ETA) guidelines as a framework. Currently, efforts are underway from the American Thyroid Association to create updated guidelines for US providers. International consensus guidelines are also underway. Until these guidelines are available, a thorough understanding of the current available guidelines is key for interventionalists building a thyroid nodule RFA program.

© 2022 Published by Elsevier Inc.